80 related articles for article (PubMed ID: 18493867)
21. Spotlight on pegfilgrastim in chemotherapy-induced neutropenia.
Frampton JE; Keating GM
BioDrugs; 2005; 19(6):405-7. PubMed ID: 16392893
[TBL] [Abstract][Full Text] [Related]
22. The molecular pathology of acute myeloid leukemia.
Licht JD; Sternberg DW
Hematology Am Soc Hematol Educ Program; 2005; ():137-42. PubMed ID: 16304371
[TBL] [Abstract][Full Text] [Related]
23. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep.
Woods WG
Pediatr Blood Cancer; 2006 May; 46(5):565-9. PubMed ID: 16261562
[TBL] [Abstract][Full Text] [Related]
24. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
Miranda MB; Xu H; Torchia JA; Johnson DE
Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
[TBL] [Abstract][Full Text] [Related]
25. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.
Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S
Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921
[TBL] [Abstract][Full Text] [Related]
26. Drug therapy for acute myeloid leukemia.
Tallman MS; Gilliland DG; Rowe JM
Blood; 2005 Aug; 106(4):1154-63. PubMed ID: 15870183
[TBL] [Abstract][Full Text] [Related]
27. The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.
Hubeek I; Litvinova E; Peters GJ; Broekhuizen R; Haarman EG; Huismans DR; Cloos J; Zwaan CM; Fleischhack G; Creutzig U; Kaspers GJ
Int J Oncol; 2004 Dec; 25(6):1823-9. PubMed ID: 15547723
[TBL] [Abstract][Full Text] [Related]
28. Growth factor priming in therapy of acute myelogenous leukemia.
Becker PS
Curr Hematol Rep; 2004 Nov; 3(6):413-8. PubMed ID: 15496274
[TBL] [Abstract][Full Text] [Related]
29. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
[TBL] [Abstract][Full Text] [Related]
30. New phenotypic, functional and electrophysiological characteristics of KG-1 cells.
Hajas G; Zsiros E; László T; Hajdú P; Somodi S; Réthi B; Gogolák P; Ludányi K; Panyi G; Rajnavölgyi E
Immunol Lett; 2004 Mar; 92(1-2):97-106. PubMed ID: 15081533
[TBL] [Abstract][Full Text] [Related]
31. Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity.
Liu WM; Powles T; Shamash J; Propper D; Oliver T; Joel S
Oncogene; 2004 Jan; 23(4):981-90. PubMed ID: 14647427
[TBL] [Abstract][Full Text] [Related]
32. Expression of functional markers in acute lymphoblastic leukemia.
Oh EJ; Kahng J; Kim Y; Kim M; Lim J; Kang CS; Min WS; Cho B; Lee A; Lee KY; Kim WI; Shim SI; Han K
Leuk Res; 2003 Oct; 27(10):903-8. PubMed ID: 12860010
[TBL] [Abstract][Full Text] [Related]
33. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
Ravindranath Y
Curr Opin Oncol; 2003 Jan; 15(1):23-35. PubMed ID: 12490758
[TBL] [Abstract][Full Text] [Related]
35. The role of drug efflux pumps in acute myeloid leukemia.
van der Kolk DM; de Vries EG; Müller M; Vellenga E
Leuk Lymphoma; 2002 Apr; 43(4):685-701. PubMed ID: 12153153
[TBL] [Abstract][Full Text] [Related]
36. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia.
Benko I; Kovács P; Szegedi I; Megyeri A; Kiss A; Balogh E; Oláh E; Kappelmayer J; Kiss C
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):499-508. PubMed ID: 11383710
[TBL] [Abstract][Full Text] [Related]
37. Human hematopoietic growth factors: old lessons and new perspectives.
Dempke W; Von Poblozki A; Grothey A; Schmoll HJ
Anticancer Res; 2000; 20(6D):5155-64. PubMed ID: 11326688
[TBL] [Abstract][Full Text] [Related]
38. Expression of functional granulocyte colony-stimulating factor receptors on human B-lymphocytic leukemia cells.
Handa A; Kashimura T; Takeuchi S; Yamamoto A; Murohashi I; Bessho M; Hirashima K
Ann Hematol; 2000 Mar; 79(3):127-31. PubMed ID: 10803934
[TBL] [Abstract][Full Text] [Related]
39. Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-assay).
Litvinova E; Gurova K; Chimishkian K; Mentkevich G
Adv Exp Med Biol; 1999; 457():585-92. PubMed ID: 10500838
[TBL] [Abstract][Full Text] [Related]
40. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
